Vanda Pharmaceuticals Inc (VM4.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 09:59PM CEST
| Previous close | 5.1000 |
| Open | 5.1000 |
| Bid | 5.0000 x 250000 |
| Ask | 5.1500 x 250000 |
| Day's range | 5.0000 - 5.1500 |
| 52-week range | 3.0400 - 6.1000 |
| Volume | |
| Avg. volume | 177 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Vanda (VNDA) Rises on Positive Data From Motion Sickness Study
Vanda's (VNDA) tradipitant appears effective in preventing vomiting associated with motion sickness in a second phase III study. Stock rises on the news.
- GuruFocus.com
Vanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Revenue Estimates
Challenges and Strategic Developments Shape the Quarter
- Insider Monkey
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript May 8, 2024 Vanda Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name is Hermine, and I will be your conference operator today. […]
© 2024 Yahoo. All rights reserved.